Leveraging Cutting‐Edge NULISA Technology for Proteomic Profiling and Biomarker Discovery in Autosomal Dominant Alzheimer's Disease

Abstract

Background: Early disease detection, preceding the onset of symptoms, continues to be one of the biggest challenges in AD research.

The paper